The following message is a courtesy copy of an article that has been posted to bionet.announce,bionet.software as well.
The Sanger Institute is pleased to announce the availability of release 2 of ACT - a DNA sequence comparison viewer. The new release can be obtained from the ACT v2 web pages: http://www.sanger.ac.uk/Software/ACT/v2/ The most important improvement in this release is the ability to compare more than two sequences. To see how this looks see the bottom of the examples page: http://www.sanger.ac.uk/Software/ACT/Examples/ This release contains all the functionality of Artemis release 5. In common with Artemis, ACT is written in Java and runs on GNU/Linux, UNIX, Macintosh (MacOS version 9 or version 10) and MS Windows systems. ------------------------------------------------------------------ Description =========== ACT (Artemis Comparison Tool) is a DNA sequence comparison viewer based on the Artemis sequence analysis and annotation tool. It can read complete EMBL and GENBANK entries or sequence in FASTA or raw format. The sequence comparison displayed by ACT will usually be the output of a blastn or tblastx search (see the user manual for details: http://www.sanger.ac.uk/Software/ACT/v2/manual/start.html) ACT distribution ================ ACT is distributed under the terms of the GNU General Public License, hence it is available for free for use by any one for any purpose. Further information =================== The ACT web pages contain documentation, download and installation instructions: http://www.sanger.ac.uk/Software/ACT/ Some examples and screenshots can be found here: http://www.sanger.ac.uk/Software/ACT/Examples For more information on Artemis is available from the Artemis web pages: http://www.sanger.ac.uk/Software/Artemis/ Mailing list ============ We welcome contributions to ACT and Artemis and suggestions for new features. An email discussion list has been set up for this purpose. To join, send a message to '[EMAIL PROTECTED]' with 'subscribe artemis' in the body (not the subject). Announcements are also sent to this list. Acknowledgements ================ The development of ACT and Artemis is funded by the Wellcome Trust's Beowulf Genomics initiative, through its support of the Pathogen Sequencing Unit.
